Masechaba M. Leketa

Masechaba M. Leketa

Auto-generated profile, based on publicly available information

Masechaba M. Leketa

Sefako Makgatho Health Sciences University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2024 in South African Family Practice
Verified
Journal Article
Open access
PDF file
MLMasechaba M. Leketa
Masechaba M. Leketa
SZSlindile Zondi
Slindile Zondi
LCLindiwe Cele
Lindiwe Cele
MMMmampedi Mathibe Mathibe
Mmampedi Mathibe Mathibe
PNPhuti Ngoepe
Phuti Ngoepe
Tuberculosis (TB) treatment success rates (TSR) remain low in Lesotho. The country achieved TSR of 76% in 2020, which is far below the World Health Organization’s 95% target set for 2030. This study determined the level of treatment success and factors associated with unfavourable treatment outcomes. This descriptive cross-sectional study used patient records to perform descriptive and logistic regression analyses. Sixty-one per cent of the 336 TB patients were male. Two hundred and eighty-nine had favourable outcomes, of which 10% died in the course of treatment. Patients ≤ 44 years old, and those with supported treatment, had lower odds of unfavourable treatment outcomes, respectively, adjusted odds ration [aOR] = 0.39 (95% CI: 0.19–0.78) and aOR = 0.22 (95% CI: 0.08–0.62), p < 0.05. Contribution: The death of patients while on TB treatment needs to be addressed, including heightened advocacy for supported treatment.